 |
|
 |
- December 1, 2008 |
|
|
Welcome to the #1 online source of information for Diabetes Specialists! An international online community of more than 10,000 Diabetes Specialists.
CME on Diabetes is a website built to transmit top-level CME conferences given by international experts in endocrinology, insulin resistance, prediabetes, metabolic syndrome and type 2 diabetes. More than 2.6 million slides have been viewed since the website launch. Thank you for your continued support and commitment!
|
|
|
| Presentation |
|
"Microalbuminuria and Kidney Disease In Type 2 Diabetes"Dr. Steven Soroka (biography)
English - 2002-11-23 - 28 minutes
|
 | (46 slides) |
Summary :
Here we will get a nephrology perspective on type 2 diabetes. Type 2 diabetes and chronic kidney disease are both common, but microalbuminuria (MAU) is more closely correlated with CVD than is kidney disease. Two important questions we have been asking ourselves are: What are the modifiable risk factors for kidney disease? And, What is the most cost effective way of treating kidney disease and preventing end stage kidney failure? Treatment of hypertension postpones renal insufficiency in diabetic nephropathy, and intensive blood pressure control has been shown to be cost effective. Studies indicate RAAS blockade as an appropriate treatment for the diabetic nephropathy patient. Both ACEs and ARBs can not only decrease the onset of new diabetes, but also decrease the albumin excretion rate, decrease cardiovascular events; and ARBs have shown to decrease end stage renal disease events (ESRD). Furthermore, studies have shown routine RAAS inhibition in all diabetics to be cost effective as well.
Learning objectives :
The participant will get a nephrology perspective on the delay of onset and treatment of diabetic nephropathy:
- Diabetes and chronic kidney disease are common
- Early, aggressive treatment is needed
- Blood pressure control is essential and cost effective
- RAAS blockade confers additional cardio renal protection
Bibliographic references :
Deira J, Diaz H, Grande J. 2003. Complete blockade of the Renin-Angiotensin system in patients with advanced diabetic nephropathy. Diabetes Care 2003 May;26(5):1635-6
Jungmann E. 2003. Prevention and treatment of diabetic nephropathy in older patients. Drugs Aging 2003;20(6):419-35
http://www.ncbi.nlm.nih.gov/
|
|
|
|
|
|
| Search our website |
 |
| |
Would you like to know more about insulin resistance? Are you looking for information pertaining to Type 2 Diabetes? You can find what you are looking for in over 2000 references available on CMEonDiabetes. |
| |
|
|
| Social |
|
| |
Let others know about this presentation.
|
|
|
|
